Early Drug Discovery and Development of Novel Cancer Therapeutics Targeting DNA Polymerase Eta (POLH) is a research paper published in Frontiers in Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIGMS NIH HHS
Grant: P41 GM103393
NIGMS NIH HHS
Grant: T32 GM008280
National Institutes of Health
Grant: 1R43CA254552-01
Targeting the DNA repair enzyme apurinic/apyrimidinic endonuclease (APE1) to treat cancer
National Institutes of Health
Grant: 3R44GM132796-03S1
Rapid Hit Generation and Lead Elaboration for SARS-CoV-2 Therapeutics
National Institutes of Health
Grant: 1R43TR001736-01
A high-throughput platform for crystallography-based fragment screening
National Institutes of Health
Grant: 3T32GM008280-27S1
Houston Area Molecular Biophysics Program
National Institutes of Health
Grant: 8P41GM103393-33
A Synchroton Radiation Structural Biology Resource
National Cancer Institute
National Center for Advancing Translational Sciences
Cancer Prevention and Research Institute of Texas
National Institute of General Medical Sciences
National Institutes of Health
Welch Foundation
FWCI
0.89
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals